Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Diagnostic Imaging Agent Pulled from Market
The FDA has issued a Public Health Advisory to inform health care providers the agency has requested the market withdrawal of the diagnostic imaging agent NeutroSpec (Technetium (99m TC) Fanolesomab) pending review of reported deaths and serious and life-threatening adverse events associated with use of the product. NeutroSpec, approved for marketing in July 2004, is a diagnostic imaging agent administered intravenously to help diagnose appendicitis in patients 5 years and older with possible appendicitis who lack its conventional signs and symptoms. News of these adverse events, including severe allergic reactions in certain patients shortly after being administered NeutroSpec, were reported to the FDA as part of the agency's post-market surveillance program. As all of the reactions occurred immediately after Neutro-Spec was administered, there is no indication that patients who already safely received the drug face any long-term risk.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.